These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. EPO patient dispute: court battle ends at the start. Gershon D Nature; 1989 Dec 21-28; 342(6252):846. PubMed ID: 2594071 [No Abstract] [Full Text] [Related]
7. ACOG Committee Opinion. Number 364 May 2007. Patents, medicine, and the interests of patients. Committees on Ethics and Genetics of American College of Obstetricians and Gynecologists Obstet Gynecol; 2007 May; 109(5):1249-54. PubMed ID: 17470613 [TBL] [Abstract][Full Text] [Related]
8. First round to Amgen in EPO battle. Robertson D Nat Biotechnol; 2000 May; 18(5):483. PubMed ID: 10802602 [No Abstract] [Full Text] [Related]
9. Building the proper foundation for genomics-based patents. Chahine KG Nat Biotechnol; 1998 Jul; 16(7):683-5. PubMed ID: 9661205 [No Abstract] [Full Text] [Related]
11. Erythropoietin in the UK: a setback for gene patents? Crespi RS Nat Biotechnol; 2005 Mar; 23(3):367-8. PubMed ID: 15765090 [No Abstract] [Full Text] [Related]
12. Patent strategies in molecular diversity. Green GD Mol Divers; 1997-1998; 3(4):247-52. PubMed ID: 9850521 [TBL] [Abstract][Full Text] [Related]
13. Use patents, carve-outs, and incentives--a new battle in the drug-patent wars. Rai A N Engl J Med; 2012 Aug; 367(6):491-3. PubMed ID: 22873529 [No Abstract] [Full Text] [Related]
15. Patents: a threat to innovation? Manocaran M Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557 [No Abstract] [Full Text] [Related]
16. How Patent Troll Legislation Can Increase Timely Access to Generic Drugs. Treasure CL; Kesselheim AS JAMA Intern Med; 2016 Jun; 176(6):729-30. PubMed ID: 27183456 [No Abstract] [Full Text] [Related]
17. [Requirements for use and patenting of drugs in the United States of America]. Ferrario V Farmaco Prat; 1972 Jun; 27(6):305-17. PubMed ID: 5032930 [No Abstract] [Full Text] [Related]
18. Reach-through claims for drug target patents: Rx for pharmaceutical policy. Bohrer RA Nat Biotechnol; 2008 Jan; 26(1):55-6. PubMed ID: 18183015 [No Abstract] [Full Text] [Related]
20. The application of the patent laws to the drug approval process. Coggio BD; Cerrito FD Food Drug Law J; 1997; 52(4):345-55. PubMed ID: 10346669 [No Abstract] [Full Text] [Related] [Next] [New Search]